ACTIVE_NOT_RECRUITING

Abbreviate or FAST Breast MRI for Supplemental Breast Cancer Screening for Black Women at Average Risk and Dense Breasts

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

500 patients will be prospectively recruited to undergo a fast breast MRI examination. The women will be recruited for the study will meet the following criteria: 1. African American 2. negative DBT examination 11 months prior to recruitment 3. Heterogeneously and Extremely breast densities 4. clinically asymptomatic- no palpable masses, focal thickening or clinically significant discharge. Investigators will identify these patients EPIC database utilizing the date of their last mammogram. Interested patients may contact our research coordinators by the phone number provided in the recruitment materials. The study recruitment information will also be shared with referring physicians. Physicians may also directly refer patients to the study.

Official Title

Supplemental Screening for Breast Cancer With Abbreviated Breast MR for Black Women With Increased Breast Density

Quick Facts

Study Start:2021-09-23
Study Completion:2028-07-13
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ACTIVE_NOT_RECRUITING

Study ID

NCT04854304

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:40 Years to 75 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. African American female
  2. 2. Negative DBT examination within eleven months prior to recruitment
  3. 3. Heterogeneoulsy and Extremely breast densities
  4. 4. Clinically asymptomatic- no palpable masses or focal thickening, etc.
  1. 1. Patients who are pregnant and lactating
  2. 2. Patient who have not had a mammogram (DBT) in the past 11months
  3. 3. Patients who are unwilling or unable to provide written informed consent
  4. 4. Patients symptomatic for breast disease (e.g. experiencing discharge, lumps, ect.)
  5. 5. Recent breast surgery in the past 2 years including breast enhancements (e.g. implants or injections)
  6. 6. Patients who are unable to received an MRI with Gadolinium contrast
  7. 7. Patients who have not had an MRI of the breast with the past year

Contacts and Locations

Principal Investigator

Emily F Conant, MD
PRINCIPAL_INVESTIGATOR
University of Pennsylvania

Study Locations (Sites)

UPENN
Philadelphia, Pennsylvania, 19104
United States

Collaborators and Investigators

Sponsor: Abramson Cancer Center at Penn Medicine

  • Emily F Conant, MD, PRINCIPAL_INVESTIGATOR, University of Pennsylvania

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-09-23
Study Completion Date2028-07-13

Study Record Updates

Study Start Date2021-09-23
Study Completion Date2028-07-13

Terms related to this study

Keywords Provided by Researchers

  • Black women
  • dense breast

Additional Relevant MeSH Terms

  • Breast Diseases